Hong Kong Stock Exchange filings indicate that on August 6, Morgan Stanley reduced its stake in NOVOSENSE (02676) by 15,687 shares, with a per-share price of approximately HK$136.21, totaling around HK$2.1367 million.

Following this reduction, the institution's current shareholding stands at roughly 1.1969 million shares, equating to a 5.95% ownership stake.